Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1672.HK Stock Summary
Top 10 Correlated ETFs
1672.HK
In the News
1672.HK Financial details
Company Rating
Neutral
Market Cap
1.6B
Income
-243.4M
Revenue
62.38M
Book val./share
2.36
Cash/share
2.32
Dividend
-
Dividend %
-
Employees
243
Optionable
No
Shortable
Yes
Earnings
25 Mar 2024
P/E
-3.59
Forward P/E
-6.81
PEG
-1.84
P/S
22.15
P/B
0.52
P/C
0.62
P/FCF
-7.64
Quick Ratio
22.94
Current Ratio
23.52
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-0.22
EPS next Y
-0.21
EPS next Q
-
EPS this Y
88.89%
EPS next Y
-1.58%
EPS next 5Y
-1.58%
EPS last 5Y
109.62%
Revenue last 5Y
-20.12%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
100%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-14%
ROE
-14%
ROC
-0.1%
Gross Margin
-46%
Oper. Margin
-486%
Profit Margin
-678%
Payout
-
Shs Outstand
1.01B
Shs Float
207.51M
-
-
-
-
Target Price
-
52W Range
1.24-2.99
52W High
-28.5%
52W Low
+43%
RSI
34
Rel Volume
0.06
Avg Volume
2.2M
Volume
140K
Perf Week
-11.18%
Perf Month
-22.7%
Perf Quarter
-25.52%
Perf Half Y
-20.11%
-
-
-
-
Beta
0.662
-
-
Volatility
0.06%, 0.14%
Prev Close
0%
Price
1.43
Change
1.42%
1672.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.19 | 0.16 | 0.03 | 0.07 | 0.05 | |
Net income per share | -0.01 | -0.15 | -0.25 | -0.18 | -0.34 | |
Operating cash flow per share | -0.11 | -0.07 | -0.08 | -0.13 | -0.13 | |
Free cash flow per share | -0.18 | -0.1 | -0.12 | -0.14 | -0.14 | |
Cash per share | 3.65 | 2.84 | 2.61 | 2.28 | 2.28 | |
Book value per share | 3.94 | 3.15 | 2.87 | 2.49 | 2.34 | |
Tangible book value per share | 3.86 | 3.08 | 2.78 | 2.42 | 2.32 | |
Share holders equity per share | 3.94 | 3.15 | 2.87 | 2.49 | 2.34 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 4.86B | 2.8B | 2.52B | 2.95B | 4.55B | |
Enterprise value | 1.68B | -188.79M | -191.83M | 454.48M | 2.08B | |
P/E ratio | -669.29 | -17.98 | -9.62 | -14.58 | -12.41 | |
Price to sales ratio | 29.21 | 16.12 | 72.01 | 38.34 | 84.12 | |
POCF ratio | -50.29 | -37.62 | -29.69 | -20.06 | -31.94 | |
PFCF ratio | -31.01 | -27.26 | -20.35 | -19.12 | -29.01 | |
P/B Ratio | 1.42 | 0.84 | 0.85 | 1.08 | 1.79 | |
PTB ratio | 1.42 | 0.84 | 0.85 | 1.08 | 1.79 | |
EV to sales | 10.13 | -1.09 | -5.48 | 5.91 | 38.52 | |
Enterprise value over EBITDA | -34.43 | 13.21 | 1.48 | -2.73 | -8.96 | |
EV to operating cash flow | -17.44 | 2.54 | 2.26 | -3.09 | -14.63 | |
EV to free cash flow | -10.75 | 1.84 | 1.55 | -2.95 | -13.28 | |
Earnings yield | 0 | -0.06 | -0.1 | -0.07 | -0.08 | |
Free cash flow yield | -0.03 | -0.04 | -0.05 | -0.05 | -0.03 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 64.85 | 208.88 | 20.98 | 14.98 | 10.6 | |
Current ratio | 36.01 | 36.42 | 38.36 | 28.93 | 23.52 | |
Interest coverage | 0 | -200.22 | -1.16K | -1.57K | -1.67K | |
Income quality | 4.86 | 0.77 | 0.41 | 0.74 | 0.45 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | -7.97 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.52 | 0.14 | 0.58 | 0.21 | 0.29 | |
Research and developement to revenue | 0.86 | 0.73 | 3.12 | 2.77 | 4.94 | |
Intangibles to total assets | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 | |
Capex to operating cash flow | 0.62 | 0.38 | 0.46 | 0.05 | 0.1 | |
Capex to revenue | -0.36 | -0.16 | -1.11 | -0.09 | -0.27 | |
Capex to depreciation | -5.02 | -1.27 | -1.43 | -0.24 | -0.48 | |
Stock based compensation to revenue | 0.03 | 0.02 | 0.13 | 0.09 | 0.06 | |
Graham number | 0.86 | 3.23 | 4.03 | 3.21 | 4.21 | |
ROIC | -0.02 | -0.02 | -0.07 | -0.07 | -0.12 | |
Return on tangible assets | 0 | -0.05 | -0.09 | -0.07 | -0.14 | |
Graham Net | 3.58 | 2.83 | 2.58 | 2.25 | 2.2 | |
Working capital | 3.27B | 3.1B | 2.76B | 2.54B | 2.44B | |
Tangible asset value | 3.35B | 3.25B | 2.89B | 2.65B | 2.52B | |
Net current asset value | 3.26B | 3.09B | 2.74B | 2.53B | 2.43B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 34.76M | 48.07M | 40.11M | 38.74M | |
Average payables | 13.58M | 10.42M | 3.79M | 992K | 2.09M | |
Average inventory | 73.04M | 84.96M | 72.47M | 57.56M | 38.38M | |
Days sales outstanding | 0 | 146.31 | 277.6 | 254.52 | 161.1 | |
Days payables outstanding | 418.43 | 49.32 | 5.8 | 10.2 | 14.52 | |
Days of inventory on hand | 2.47K | 638.82 | 367.47 | 544.39 | 95.07 | |
Receivables turnover | 0 | 2.49 | 1.31 | 1.43 | 2.27 | |
Payables turnover | 0.87 | 7.4 | 62.9 | 35.77 | 25.13 | |
Inventory turnover | 0.15 | 0.57 | 0.99 | 0.67 | 3.84 | |
ROE | 0 | -0.05 | -0.09 | -0.07 | -0.14 | |
Capex per share | -0.07 | -0.03 | -0.04 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.01 | 0.01 | 0.02 | 0.02 | |
Net income per share | 0 | -0.1 | -0.1 | -0.01 | -0.01 | |
Operating cash flow per share | 0 | -0.03 | -0.03 | -0.03 | -0.03 | |
Free cash flow per share | 0 | -0.04 | -0.04 | -0.03 | -0.03 | |
Cash per share | 0 | 2.28 | 2.28 | 2.31 | 2.32 | |
Book value per share | 0 | 2.34 | 2.34 | 2.36 | 2.36 | |
Tangible book value per share | 0 | 2.32 | 2.32 | 2.35 | 2.35 | |
Share holders equity per share | 0 | 2.34 | 2.34 | 2.36 | 2.36 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 2.71B | 4.55B | 2.38B | 1.89B | |
Enterprise value | -2.48B | 238.79M | 2.08B | 1.91B | 1.42B | |
P/E ratio | 0 | -5.97 | -10.03 | -71.74 | -57.02 | |
Price to sales ratio | 0 | 341.43 | 573.42 | 102.17 | 81.21 | |
POCF ratio | 0 | -72.37 | -121.54 | -69.92 | -55.58 | |
PFCF ratio | 0 | -70.34 | -118.14 | -68.06 | -54.1 | |
P/B Ratio | 0 | 1.07 | 1.79 | 0.92 | 0.74 | |
PTB ratio | 0 | 1.07 | 1.79 | 0.92 | 0.74 | |
EV to sales | 0 | 30.09 | 262.61 | 81.97 | 61.14 | |
Enterprise value over EBITDA | 0 | -2.26 | -19.71 | -52.05 | -38.82 | |
EV to operating cash flow | 0 | -6.38 | -55.66 | -56.09 | -41.84 | |
EV to free cash flow | 0 | -6.2 | -54.1 | -54.61 | -40.73 | |
Earnings yield | 0 | -0.04 | -0.02 | 0 | 0 | |
Free cash flow yield | 0 | -0.01 | -0.01 | -0.01 | -0.02 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 23.37 | 23.33 | 12.83 | 12.74 | |
Current ratio | 26.26 | 23.52 | 23.52 | 30.82 | 30.82 | |
Interest coverage | 0 | 0 | -996.93 | 0 | -510.52 | |
Income quality | 0 | 0.33 | 0.33 | 4.1 | 4.1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 1.09 | 1.09 | 0.56 | 0.56 | |
Research and developement to revenue | 0 | 9.34 | 9.34 | 1.98 | 1.98 | |
Intangibles to total assets | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to revenue | 0 | -0.14 | -0.14 | -0.04 | -0.04 | |
Capex to depreciation | 0 | -0.16 | -0.16 | -0.21 | -0.21 | |
Stock based compensation to revenue | 0 | 0.08 | 0.08 | 0.04 | 0.04 | |
Graham number | 0 | 2.34 | 2.34 | 0.64 | 0.64 | |
ROIC | 0 | -0.04 | -0.05 | -0.02 | -0.04 | |
Return on tangible assets | 0 | -0.04 | -0.04 | 0 | 0 | |
Graham Net | 0 | 2.19 | 2.2 | 2.25 | 2.25 | |
Working capital | 2.53B | 2.44B | 2.44B | 2.48B | 2.48B | |
Tangible asset value | 2.63B | 2.52B | 2.52B | 2.55B | 2.55B | |
Net current asset value | 2.53B | 2.43B | 2.43B | 2.48B | 2.48B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 11.94M | 23.87M | 14.75M | 5.64M | |
Average payables | 0 | 4.55M | 3.14M | 5.04M | 6.95M | |
Average inventory | 0 | 41.76M | 20.52M | 23.97M | 27.42M | |
Days sales outstanding | 0 | 270.74 | 270.74 | 21.81 | 21.81 | |
Days payables outstanding | 0 | 8.69 | 8.69 | 158.7 | 158.7 | |
Days of inventory on hand | 0 | 56.88 | 56.88 | 625.78 | 625.78 | |
Receivables turnover | 0 | 0.33 | 0.33 | 4.13 | 4.13 | |
Payables turnover | 0 | 10.36 | 10.36 | 0.57 | 0.57 | |
Inventory turnover | 0 | 1.58 | 1.58 | 0.14 | 0.14 | |
ROE | 0 | -0.04 | -0.04 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
1672.HK Frequently Asked Questions
What is Ascletis Pharma Inc. stock symbol ?
Ascletis Pharma Inc. is a CN stock and trading under the symbol 1672.HK
What is Ascletis Pharma Inc. stock quote today ?
Ascletis Pharma Inc. stock price is $1.43 today.
Is Ascletis Pharma Inc. stock public?
Yes, Ascletis Pharma Inc. is a publicly traded company.